Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. - Wikidata - wikimedia - TriplyDB

Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection.

Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection.

http://www.wikidata.org/entity/Q33204250

about

Actin-binding proteins coronin-1a and IBA-1 are effective microglial markers for immunohistochemistry The use of neuroproteomics in drug abuse research Widespread protein aggregation as an inherent part of aging in C. elegans Role of platelets in neuroinflammation: a wide-angle perspective Identification and characterization of neuronal mitogen-activated protein kinase substrates using a specific phosphomotif antibody.Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALS.Neuroproteomics approaches to decipher neuronal regeneration and degeneration.Proteomic analysis of hippocampal dentate granule cells in frontotemporal lobar degeneration: application of laser capture technology.Late-onset Alzheimer's disease, heating up and foxed by several proteins: pathomolecular effects of the aging process.The biochemical aftermath of anti-amyloid immunotherapy.Global analysis of protein aggregation in yeast during physiological conditions and arsenite stress.Concerted perturbation observed in a hub network in Alzheimer's disease Integrated approaches for analyzing U1-70K cleavage in Alzheimer's disease.A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease.Proteolytically inactive insulin-degrading enzyme inhibits amyloid formation yielding non-neurotoxic aβ peptide aggregates Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease.Using In silico LD clumping and meta-analysis of genome-wide datasets as a complementary tool to investigate and validate new candidate biomarkers in Alzheimer's disease.Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease Proteomic analysis of laser capture microscopy purified myotendinous junction regions from muscle sections Proteomics in neurodegenerative diseases: Methods for obtaining a closer look at the neuronal proteome.The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study.Enrichment of single neurons and defined brain regions from human brain tissue samples for subsequent proteome analysis.Laser capture microdissection: from its principle to applications in research on neurodegeneration.η-Secretase processing of APP inhibits neuronal activity in the hippocampus.Proteomic analysis of neurons microdissected from formalin-fixed, paraffin-embedded Alzheimer's disease brain tissue 14-3-3ζ Mediates Tau Aggregation in Human Neuroblastoma M17 Cells.Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome.Proteomic characterization of neuromelanin granules isolated from human substantia nigra by laser-microdissection.Molecular Mapping Alzheimer's Disease: MALDI Imaging of Formalin-fixed, Paraffin-embedded Human Hippocampal Tissue Determining composition of micron-scale protein deposits in neurodegenerative disease by spatially targeted optical microproteomics.How proteomics reveals potential biomarkers in brain diseases.Recent advances in applying mass spectrometry and systems biology to determine brain dynamics.Genetics, transcriptomics, and proteomics of Alzheimer's disease Liquid chromatography with tandem mass spectrometry-based proteomic discovery in aging and Alzheimer's disease.Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?Two-dimensional gels for toxicological drug discovery applications.Signaling, polyubiquitination, trafficking, and inclusions: sequestosome 1/p62's role in neurodegenerative disease.Use of proteomics for the identification of novel drug targets in brain diseases.Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers.A transcriptional signature of Alzheimer's disease is associated with a metastable subproteome at risk for aggregation

P2860

Q24299193-02A3BE06-9342-4BD6-BF91-4C4064B543C9 Q27010380-218B4D11-4BFE-4806-8903-9DCEDD2E0CC1 Q27323997-957A4770-0961-4FFE-9BE9-E6B88F1FE4A6 Q28393808-BBFFA5AD-AB8E-4A79-8518-F796F75B0F9C Q33389393-A38E8AE2-1832-4566-AAF3-C3C9A8C1D386 Q33719399-06461C12-9D9A-4577-8806-B23E843FF232 Q33855014-7754E671-381B-4C01-99C3-FFF3A40A1D65 Q33902176-C7C7352F-2EE3-4864-80A2-309848AF9A59 Q34020079-8DF50EC2-4519-468A-BEFF-50D86A4A0270 Q34221510-64E549ED-BAF6-44E1-BDFC-6AAAAD19F185 Q34340978-9691E228-8E8F-4BCC-A063-84840233BDA3 Q34344867-031D5652-50E0-4607-844D-E0A3CDE7546B Q34488564-9C30EEB4-3933-49F2-9453-29E47E5A471E Q34658144-A4D2F161-7F9F-479E-917C-9F0399275B3B Q34672360-A2E2A4A4-5570-47A8-9035-B034F6CDD0F5 Q34695804-0FA03082-BB12-41A7-810E-F0D11B580359 Q34793871-EA41408E-7BBF-4E31-BA6C-40E4A9B31EE4 Q35125001-C9B0AC8D-F5CA-43FB-9A12-5110407F6B3A Q35214744-8A78B32F-7F26-439C-BD72-F85A888CCE88 Q35241298-757AE3C0-7E17-4017-AFD0-18D75EDFFD42 Q35632339-F4C63C76-FE3D-43BA-9AE5-41E8E0958FFB Q35678116-49423F11-6EEB-4D05-BA2A-980A57796961 Q35704842-C8125969-3638-4A99-A2E8-D4ECF4423121 Q35760228-A929969E-CC07-4A5E-9B7D-9C6B1175CB8D Q35815555-7C246E16-98C6-4E6A-8106-DCFFF5CA3FD9 Q36109281-E712DAC9-E69D-4427-B271-B2BA31689326 Q36136732-7B5C2051-6D01-4BF6-A2D5-5D64E098FC7F Q36191442-39A5A3D5-37A7-4FCC-9E27-00DDF9F2A0BF Q36192321-4DDBC2D1-BD85-4568-9739-FB9E7FE90673 Q36242304-64040B06-8AE7-4832-B1E1-FFEEAB9975C5 Q36322155-70917AAE-951A-4F9B-9C11-08A6229C82F4 Q36379339-D1E47FDB-AEAE-41BA-A02C-142B63C1B85F Q36466472-9665E33D-55B3-4EF1-AD8E-524474D8DD97 Q36525167-D2D17BE9-7E16-468A-8EE6-01BDF36446CB Q36539454-D6F14445-1B03-4796-8458-C3808F54DC0C Q36545048-4CD96EB1-6EA2-4EC3-8281-167A25EDD876 Q36626380-9C87A6FF-FF7D-4B34-A77F-0D4CF6566441 Q36785927-B15D031B-1096-4ADF-8FC6-5ADA6B15D954 Q36787240-BFB8850E-060A-4189-9229-DB625E791406 Q36866261-457AD159-D01F-4FD0-85E6-EE399E58F531

P2860

Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection.

http://www.wikidata.org/entity/Q33204250

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Proteomic characterization of ...... laser capture microdissection.

@ast

Proteomic characterization of ...... laser capture microdissection.

@en

type

label

Proteomic characterization of ...... laser capture microdissection.

@ast

Proteomic characterization of ...... laser capture microdissection.

@en

prefLabel

Proteomic characterization of ...... laser capture microdissection.

@ast

Proteomic characterization of ...... laser capture microdissection.

@en

P1433

Q33204250-CE931955-00E1-426D-BDA0-6F6E97752B4F

P1476

Q33204250-25AE5796-BED4-478E-885A-4A1866A84C5A

P2093

Q33204250-03E5A22D-AA52-4B1F-9E8C-110197C28F06

Q33204250-400F0DC1-C34E-4FC2-9B83-D10906E30E40

Q33204250-43C1C12C-08A9-47FF-8584-7546BC701CEB

Q33204250-6E7A00DA-CC95-44D9-B3AA-AF861562FA2A

Q33204250-811F97E4-BF9B-43A6-B662-BE78EF629650

Q33204250-8FD373E1-02A1-4948-80D5-58A0A3A50473

Q33204250-ABFCF5AB-9618-40FF-BF5C-FFB3B30623F3

Q33204250-D2041FB2-A606-4826-B9CF-47867D4FE9F9

Q33204250-D4E13B3E-98BA-47A6-99C6-E75F4832F336

Q33204250-D842EAE7-8FD6-4B9F-97C2-9F3DFEDAFE01

P2860

Q33204250-04411BDF-D833-41F4-ABA0-CE8D7C6EC3F3

Q33204250-09D481BF-E5FD-4896-B0AB-10CD47C5600C

Q33204250-0B695920-50C6-4D7A-BD6C-4155CF68FB93

Q33204250-0C537AC0-CBD2-420A-BC5F-45A211425A48

Q33204250-0C866F85-2B1B-4098-B0C0-152A32588FB8

Q33204250-20CA36F8-6682-4BA4-8F04-FE948B143342

Q33204250-2294D255-010B-4392-AE77-D2199C8489A1

Q33204250-234FD5A1-A757-4441-9A02-B14E4F061B09

Q33204250-244697E2-12B0-458E-AF98-3E3817B7D1D5

Q33204250-282B7FA3-FEBD-47E4-A57C-71FEB84A0FE4

P304

Q33204250-DB41DE15-D968-463D-9C06-360914A04A0C

P31

Q33204250-575CF222-5ECD-4F82-A7F0-11AC5555A8E9

P356

Q33204250-6C7EADF7-7DF7-499B-85F4-E2910DDC714A

P407

Q33204250-A13471F1-71FB-46F2-9E6A-6B58E28416CB

P433

Q33204250-45B04929-63D7-45F8-B8B0-EAFC877C5A87

P478

Q33204250-73E2612E-3CBF-422D-931C-AA1CA194ACB3

P577

Q33204250-FFB83EEF-147C-4486-BC67-4D544EAF8842

P698

Q33204250-8EC2A2DA-5563-4D80-B5D0-03E81F112998

P356

P1433

Journal of Biological Chemistry

P1476

Proteomic characterization of ...... laser capture microdissection.

@en

P2093

Allan I Levey

http://www.w3.org/2001/XMLSchema#string

Dongmei Cheng

http://www.w3.org/2001/XMLSchema#string

Duc M Duong

http://www.w3.org/2001/XMLSchema#string

Howard D Rees

http://www.w3.org/2001/XMLSchema#string

James J Lah

http://www.w3.org/2001/XMLSchema#string

Jian Wang

http://www.w3.org/2001/XMLSchema#string

Junmin Peng

http://www.w3.org/2001/XMLSchema#string

Lujian Liao

http://www.w3.org/2001/XMLSchema#string

Marla Gearing

http://www.w3.org/2001/XMLSchema#string

Tatyana G Losik

http://www.w3.org/2001/XMLSchema#string

P2860

14-3-3zeta is an effector of tau protein phosphorylation

Directed proteomic analysis of the human nucleolus

CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV

A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling

Proteomic characterization of the human centrosome by protein correlation profiling

Amyloid plaque core protein in Alzheimer disease and Down syndrome

Large-scale proteomic analysis of the human spliceosome

Identification of septins in neurofibrillary tangles in Alzheimer's disease

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

P304

37061-37068

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M403672200

http://www.w3.org/2001/XMLSchema#string

P407

P433

35

http://www.w3.org/2001/XMLSchema#string

P478

279

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15220353

http://www.w3.org/2001/XMLSchema#string